share_log

CVS Health | 4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-Officer Joyner J. David

SEC ·  Dec 27 05:13

Summary by Moomoo AI

CVS Health Corp's President and CEO, Joyner J. David, reported holding a total of 84,922 shares as of November 30, 2024. This disclosure provides insight into the executive's stake in the company.The reported holdings consist of two types of securities: 40,681 shares of Common Stock held directly, and 44,241 shares of Restricted Common Stock, also held directly. The restricted shares likely represent part of the executive's compensation package, subject to vesting conditions.This level of stock ownership by the CEO aligns with common practices for executive compensation and demonstrates a financial stake in the company's performance. The report offers transparency into the chief executive's equity position in CVS Health.
CVS Health Corp's President and CEO, Joyner J. David, reported holding a total of 84,922 shares as of November 30, 2024. This disclosure provides insight into the executive's stake in the company.The reported holdings consist of two types of securities: 40,681 shares of Common Stock held directly, and 44,241 shares of Restricted Common Stock, also held directly. The restricted shares likely represent part of the executive's compensation package, subject to vesting conditions.This level of stock ownership by the CEO aligns with common practices for executive compensation and demonstrates a financial stake in the company's performance. The report offers transparency into the chief executive's equity position in CVS Health.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more